http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31850614

Outgoing Links

Predicate Object
contentType Clinical Trial|Clinical Trial, Phase II|Journal Article|Research Support, Non-U.S. Gov't
endingPage 673
issn 0007-0920
1532-1827
issueIdentifier 5
pageRange 669-673
publicationName British Journal of Cancer
startingPage 669
bibliographicCitation Polee MB, Eskens FALM, van der Burg MEL, Splinter TAW, Siersema PD, Tilanus HW, Verweij J, Stoter G, van der Gaast A. Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer. British Journal of Cancer. 2002 Feb 26;86(5):669–73. doi: 10.1038/sj.bjc.6600166.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0e5520127b372941b3a545a39266eed
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58495b747b778e36163208b3764a3bb0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9abcbc924c9ec93ee802991fff4ba547
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b847cfceb6b5da4d8e215ef1682e3a7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2127a6a44addc34fec6c8d0630bcf1de
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1162ce5d76c4b08b1769abbdbf2be20f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ca0dd05037bef8ed285f6245aff561d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebef5cfd97485d95657ad2c7dde9339c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_856095b7629b95744880e3bf1f7fdb6e
date 2002-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2375296
https://doi.org/10.1038/sj.bjc.6600166
https://pubmed.ncbi.nlm.nih.gov/11875723
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/1532-1827
https://portal.issn.org/resource/ISSN/0007-0920
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer
discusses http://id.nlm.nih.gov/mesh/M0026156
http://id.nlm.nih.gov/mesh/M0004505
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7652
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7947

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136177720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129430288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135935854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136123131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129108869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129307185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136018285

Total number of triples: 52.